Let’s dig into the relative performance of Biogen (NASDAQ:BIIB) and its peers as we unravel the now-completed Q4 therapeutics earnings season.

Earnings results often indicate what direction a company will take in the months ahead. With Q4 behind us, let’s have a look ...

There's no easy way to identify the most hated stocks on Wall Street, but looking at the activity of short sellers is a great place to start. Short selling is a difficult art that involves ...

However, the vaccine manufacturers concerned may appeal against this decision in order to protect their professional, commercial and manufacturing secrets, the Federal Office of P ...

BioNTech (BNTX) stock tumbles 17% after reporting Q4 losses, missing 2026 revenue projections, and announcing co-founder departures. Full analysis here.

Food and Drug Administration (FDA) Commissioner Marty Makary on Friday announced that the agency’s top regulator Vinay Prasad ...

Novavax, Inc. Is a biotechnology company, which engages in the discovery, development, and commercialization of recombinant vaccines. The company was founded in 1987 and is headquartered in ...

Moderna (NasdaqGS:MRNA) has reached a global settlement with Genevant Sciences and Arbutus Biopharma over lipid nanoparticle technology used in its Covid 19 vaccines. The agreement includes a ...

There has traditionally been a comforting certainty that healthcare companies provide ballast in a portfolio. It was long ...

The German biotech provides a weak full-year outlook and announces the exit of its co-founders.